(Q54015372)

23 May 2018

title

Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure. (English)

1 reference

23 May 2018

0 references

1 reference

congestive heart failure

1 reference

J H Patterson

1

1 reference

23 May 2018

K F Adams

2

1 reference

23 May 2018

M Gheorghiade

3

1 reference

23 May 2018

R C Bourge

4

1 reference

23 May 2018

C A Sueta

5

1 reference

23 May 2018

S W Clarke

6

1 reference

23 May 2018

J P Jankowski

7

1 reference

23 May 2018

C L Shaffer

8

1 reference

23 May 2018

R A McKinnis

9

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 January 1995

1 reference

23 May 2018

American Journal of Cardiology

published in

1 reference

23 May 2018

volume

75

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

26A-33A

1 reference

23 May 2018

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Prostaglandin modulation of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium chloride combined with efferent cardiac sympathetic stimulation in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

The effects of I5AU8I, a chemically stable prostacyclin analog, on the cardiovascular and renin-angiotensin systems of anesthetized dogs [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Right ventricular ejection fraction: An indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Evidence for a direct stimulatory effect of prostacyclin on renin release in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Hemodynamic, Hormonal, and Renal Effects of the Prostacyclin Analogue Iloprost in Conscious Dogs With and Without Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Acute hemodynamic (systemic and renal) and humoral effects of three increasing doses of iloprost in essential hypertensives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Effects of a prostacyclin analog iloprost on kidney function, renin-angiotensin and kallikrein-kinin systems, prostanoids and catecholamines in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Prostacyclin therapy in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980380-4

10.1016/S0002-9149(99)80380-4

7 January 2021

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

7840051

1 reference

23 May 2018